The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.
Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 ...
The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.